AmerStem, Inc.


AmerStem develops and operates a plant-based biotechnology platform for indoor cultivation and scalable production of plant-derived bioactive compounds. The company focuses on sustainable, resource-efficient biomass growth and green extraction methods to produce saponin immunoadjuvants and other phytochemicals for vaccine development, pharmaceuticals, agriculture, and personal care.

Industries

N/A

Nr. of Employees

small (1-50)

AmerStem, Inc.

Camarillo, California, USA


Products

Saponin immunoadjuvant extracts (QS-21 class)

Purified saponin-class immunoadjuvant extracts produced via cultivated plant biomass and green extraction workflows; intended as an alternative source to wild-harvested tree-derived saponins.


Services

Provision of controlled-environment cultivation services to grow plant biomass at commercial scale for extraction of targeted phytochemicals.

Green extraction and downstream purification services for recovery of high-value phytochemicals, including saponin-class immunoadjuvants.

Collaborative R&D programs to optimize plant culture systems, increase target metabolite yields, and translate plant-derived compounds into applications such as vaccine adjuvants and crop protection agents.

Expertise Areas

  • Plant cell and tissue culture
  • Indoor/vertical farming for biomass production
  • Biopharming and plant-based recombinant protein production
  • Saponin immunoadjuvant production
  • Show More (4)

Key Technologies

  • Hairy root culture
  • Plant cell and tissue culture
  • Indoor controlled-environment agriculture / vertical farming
  • Elicitor-based induction of secondary metabolism
  • Show More (4)

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.